Abstract: A transmission antenna switching method includes: in a case that the terminal device is in a dual network connected state, determining a first network used to transmit control plane data and a second network only used to transmit user plane data; determining a working mode of the second network in a case that an SRS switching request is received; determining a priority order of transmission antenna switching in the first network and the second network according to the working mode of the second network; and performing SRS antenna switching in the first network according to the priority order.

Abstract: A modified nucleoside or nucleotide, the 3?-OH of the modified nucleoside or nucleotide being reversibly blocked; meanwhile, the present invention also relates to a kit comprising the nucleoside or nucleotide, and a sequencing method based on the nucleoside or nucleotide.

Abstract: A radio frequency structure includes: a radio frequency front-end module, a switch module, and an antenna module. The radio frequency front-end module includes a radio frequency transceiver, and a first processing module, a second processing module, a third processing module, a fourth processing module, and a fifth processing module that are connected to the radio frequency transceiver. The switch module includes a first switch module and a second switch module. The antenna module includes a first antenna, a second antenna, a third antenna, and a fourth antenna that are used to receive or send radio frequency signals.

Abstract: The present disclosure provides a transmit antenna switching method and a terminal device. The method includes: when the terminal device is in a dual-network connected state, determining a first network used to transmit control plane data and a second network only used to transmit user plane data, where the dual-network connected state is that the terminal device is simultaneously connected to the first network and the second network; determining, based on a transmit antenna used by the first network, a first transmit mode for switching an SRS antenna operating in the second network; and performing the SRS antenna switching based on the first transmit mode by using a first antenna set, where the first antenna set is all antennas used for the dual-network connected state included in the terminal device except the transmit antenna used by the first network.

Abstract: A dual Subscriber Identity Module (SIM) communication method and apparatus for a terminal, a device, and a storage medium are provided. The method includes: determining whether slots of dual SIM cards are aligned. The method further includes when the slots of the dual SIM cards are not aligned, within an uplink slot of a second SIM card, controlling the second SIM card to transmit a signal by using a main antenna; for an odd-numbered downlink slot of the second SIM card, controlling the second SIM card to receive a signal by using a diversity antenna within the entire odd-numbered downlink slot, and controlling a first SIM card to transmit a signal by using the main antenna in a preceding time period within the odd-numbered downlink slot and to receive a signal by using the main antenna in a later time period within the odd-numbered downlink slot.

Abstract: A radio frequency circuit includes a radio frequency front-end module, a switch module and an antenna module. The radio frequency front-end module includes a radio frequency transceiver and a first processing module connected to the radio frequency transceiver, the antenna module includes an antenna for receiving or transmitting a radio frequency signal, and the first processing module is configured to transmit a signal of a first network and a signal of a second network.

Abstract: Aspects of the present disclosure relate to genetically altered plants having a heterologous EPR3 or EPR3-like polypeptide or a modified EPR3 or EPR3-like polypeptide and/or having a heterologous EPR3a or EPR3a-like polypeptide or a modified EPR3a or EPR3a-like polypeptide, wherein the EPR3 or EPR3-like polypeptide and/or the EPR3a or EPR3a-like polypeptide provide increased selectivity for a beneficial commensal microbe as compared to a wild-type plant under the same conditions. Other aspects of the present disclosure relate to methods of making such plants as well as cultivating these genetically altered plants. Additional aspects of the present disclosure relate to methods of identifying a beneficial commensal microbe capable of interacting with a plant root microbiota.

Abstract: A radio frequency circuit includes a radio frequency front-end module, a switch module and an antenna module. The radio frequency front-end module includes a radio frequency transceiver and a first processing module connected to the radio frequency transceiver, the antenna module includes an antenna for receiving or transmitting a radio frequency signal, and the first processing module is configured to transmit a signal of a first network and a signal of a second network.

Abstract: A transmission antenna switching method includes: in a case that the terminal device is in a dual network connected state, determining a first network used to transmit control plane data and a second network only used to transmit user plane data; determining a working mode of the second network in a case that an SRS switching request is received; determining a priority order of transmission antenna switching in the first network and the second network according to the working mode of the second network; and performing SRS antenna switching in the first network according to the priority order.

Abstract: The present disclosure provides a transmit antenna switching method and a terminal device. The method includes: when the terminal device is in a dual-network connected state, determining a first network used to transmit control plane data and a second network only used to transmit user plane data, where the dual-network connected state is that the terminal device is simultaneously connected to the first network and the second network; determining, based on a transmit antenna used by the first network, a first transmit mode for switching an SRS antenna operating in the second network; and performing the SRS antenna switching based on the first transmit mode by using a first antenna set, where the first antenna set is all antennas used for the dual-network connected state included in the terminal device except the transmit antenna used by the first network.

Abstract: Non-fault disturbance-based method and system for measuring short-circuit capacity of a power grid on site including: connecting or disconnecting a reactive compensation device to or from a power grid point of common coupling, to generate a disturbance on a power grid; obtaining total active power and total reactive power of a load of the point of common coupling before the disturbance; determining a vector difference between a voltage of the power grid point of common coupling before the disturbance and a voltage of the power grid point of common coupling after the disturbance; obtaining a voltage effective value of the power grid point of common coupling before the disturbance; obtaining a capacity of the reactive compensation device; and determining a short-circuit capacity of the point of common coupling according to total active power, total reactive power, vector difference between voltages, voltage effective value, and capacity of the reactive compensation device.

Abstract: A radio frequency structure includes: a radio frequency front-end module, a switch module, and an antenna module. The radio frequency front-end module includes a radio frequency transceiver, and a first processing module, a second processing module, a third processing module, a fourth processing module, and a fifth processing module that are connected to the radio frequency transceiver. The switch module includes a first switch module and a second switch module. The antenna module includes a first antenna, a second antenna, a third antenna, and a fourth antenna that are used to receive or send radio frequency signals.

Abstract: An improved method for making a P. vulgaris bean extract that results in an extract having high ?-amylase inhibitory activity and low hemagglutinin activity. The method involves treating the beans to selectively denature the hemagglutinin. A P. vulgaris bean extract is provided, having high ?-amylase inhibitory activity and low hemagglutinin activity. A treatment for diabetes or method for reducing blood glucose level is disclosed using the P. vulgaris bean extract disclosed herein.

Abstract: Non-fault disturbance-based method and system for measuring short-circuit capacity of a power grid on site including: connecting or disconnecting a reactive compensation device to or from a power grid point of common coupling, to generate a disturbance on a power grid; obtaining total active power and total reactive power of a load of the point of common coupling before the disturbance; determining a vector difference between a voltage of the power grid point of common coupling before the disturbance and a voltage of the power grid point of common coupling after the disturbance; obtaining a voltage effective value of the power grid point of common coupling before the disturbance; obtaining a capacity of the reactive compensation device; and determining a short-circuit capacity of the point of common coupling according to total active power, total reactive power, vector difference between voltages, voltage effective value, and capacity of the reactive compensation device.

Abstract: An improved method for making a p. vulgaris bean extract that results in an extract having high ?-amylase inhibitory activity and low hemagglutinin activity. The method involves treating the beans to selectively denature the hemagglutinin. A p. vulgaris bean extract is provided, having high ?-amylase inhibitory activity and low hemagglutinin activity. A treatment for diabetes or method for reducing blood glucose level is disclosed using the p. vulgaris bean extract disclosed herein.

Abstract: The invention discloses a human cancer-related gene, LAPTM4B, its encoded products and their applications thereof. This human cancer-related gene provided by this invention comprises one of the following nucleotide sequences: (1) SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings; (2) Polynucleotides that encode the protein sequences of SEQ ID No: 4, SEQ ID No: 5, or SEQ ID No: 7 in the sequence listings; (3) DNA sequences having above 90% homology with the DNA sequences specified by SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings, and these DNA sequences encode the proteins with the same or similar functions. This invention enables the developments of new anti-cancer approaches and new anti-cancer medicines. It would create a significant impact on human society.

Abstract: The invention discloses a human cancer-related gene, LAPTM4B, its encoded products and their applications thereof. This human cancer-related gene provided by this invention comprises one of the following nucleotide sequences: (1) SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings; (2) Polynucleotides that encode the protein sequences of SEQ ID No: 4, SEQ ID No: 5, or SEQ ID No: 7 in the sequence listings; (3) DNA sequences having above 90% homology with the DNA sequences specified by SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings, and these DNA sequences encode the proteins with the same or similar functions. This invention enables the developments of new anti-cancer approaches and new anti-cancer medicines. It would create a significant impact on human society.

Abstract: The invention discloses a human cancer-related gene, LAPTM4B, its encoded products and their applications thereof. This human cancer-related gene provided by this invention comprises one of the following nucleotide sequences: (1) SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings; (2) SEQ ID No: 4, SEQ ID No: 5, or SEQ ID No: 7 in the sequence listings which are proteins encoded by the polynucleotides in sequences of SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3 and SEQ ID No: 6. (3) Applications of the polynucleotides and polypeptides in the listings in diagnosis and treatments of cancer. This invention enables the developments of new cancer diagnostic markers and new anti-cancer medicines. It would create a significant impact on human society.

Abstract: The invention discloses a human cancer-related gene, LAPTM4B, its encoded products and their applications thereof. This human cancer-related gene provided by this invention comprises one of the following nucleotide sequences: (1) SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings; (2) Polynucleotides that encode the protein sequences of SEQ ID No: 4, SEQ ID No: 5, or SEQ ID No: 7 in the sequence listings; (3) DNA sequences having above 90% homology with the DNA sequences specified by SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings, and these DNA sequences encode the proteins with the same or similar functions. This invention enables the developments of new anti-cancer approaches and new anti-cancer medicines. It would create a significant impact on human society.

Abstract: The invention discloses a human cancer-related gene, LAPTM4B, its encoded products and their applications thereof. This human cancer-related gene provided by this invention comprises one of the following nucleotide sequences: (1) SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings; (2) Polynucleotides that encode the protein sequences of SEQ ID No: 4, SEQ ID No: 5, or SEQ ID No: 7 in the sequence listings; (3) DNA sequences having above 90% homology with the DNA sequences specified by SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings, and these DNA sequences encode the proteins with the same or similar functions. This invention enables the developments of new anti-cancer approaches and new anti-cancer medicines. It would create a significant impact on human society.